Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers

NCT05279495 is registered in ClinicalTrials.gov with MINO Labs, LLC as lead sponsor.

NCT NCT05279495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers
Lead sponsor
MINO Labs, LLC
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2023
Completion date
May 15, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photoaging